ESC 2022 Guidelines — Ventricular Arrhythmias and Sudden Cardiac Death
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
This is the largest topic in the bank, and the breadth is the guideline's own. It runs from the public health end — bystander response, defibrillator availability, volunteer alerting — through acute management to inherited arrhythmia syndromes and the evaluation of families after an unexplained death.
The acute questions turn on one discipline: a wide-complex tachycardia of unknown mechanism is treated as ventricular. Calcium channel blockers are excluded. Prophylactic antiarrhythmic therapy in the acute coronary setting has a Class III statement attached, beta-blockers excepted.
Device indications are examined as sequences rather than single thresholds — optimal medical therapy, a reassessment interval, then the implant decision. The channelopathies have drug-specific answers worth knowing exactly: non-selective beta-blockade in long QT syndrome, and the investigations that are explicitly not indicated there.
What is in the bank
356 active questions. Class and level follow the recommendation each question is built from.